Hysteroscopy instruments market seen reaching $2.71 billion by 2030

The hysteroscopy instruments market is projected to grow from $1.82 billion in 2025 to $2.71 billion by 2030, driven by more gynecological procedures, better imaging and rising demand for minimally invasive care. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Hysteroscopy instruments are used to diagnose and treat uterine conditions with a minimally invasive approach. - Demand is rising as providers expand gynecological care and patients seek outpatient and fertility-related procedures. - Growth in the market points to broader adoption of tools that can support earlier diagnosis and treatment of uterine disorders.

What happened: - The Business Research Company projected the global hysteroscopy instruments market will rise from $1.82 billion in 2025 to $1.98 billion in 2026. - The market is forecast to reach $2.71 billion by 2030. - The report put 2025-2026 growth at a 8.6% CAGR and the 2026-2030 forecast at 8.3% CAGR. - The report was released Aug. 11, 2026. - A free sample of the report is available here. - The full market report is available here.

The details: - Historical growth was linked to rising uterine disorder prevalence, more hospital-based gynecological procedures, wider use of conventional diagnostic hysteroscopy, basic endoscopic technology improvements and greater awareness of women’s health diagnostics. - Hysteroscopy instruments include devices used to view the uterus through a thin, illuminated tube inserted through the vagina. - The tools support both diagnostic and therapeutic uses, including biopsies and removal of abnormal tissue. - The market’s growth drivers include more gynecological disorders, innovations in hysteroscopic imaging systems, a shift toward ambulatory surgery centers and stronger demand for fertility and reproductive health procedures. - Disposable instruments are gaining preference as providers try to reduce infection risk. - Favorable reimbursement policies and expanding healthcare infrastructure are also supporting growth. - Key trends include greater use of minimally invasive gynecological procedures, single-use hysteroscopy devices, office-based and outpatient hysteroscopy, better visualization and imaging quality and broader use of operative hysteroscopy for treatment. - Gynecological disorders affect the uterus, ovaries, fallopian tubes and vagina. - The market helps address conditions such as uterine fibroids, polyps, abnormal bleeding and endometrial hyperplasia. - The American Cancer Society reported female genital cancer cases in the US rose from 114,810 in 2023 to 116,930 in 2024, a 1.85% increase.

Between the lines: - The forecast suggests hospitals and clinics are moving toward more precise, less invasive procedures that can be performed outside traditional surgical settings. - Disposable and office-based tools point to a market that is being shaped as much by infection control and convenience as by clinical capability. - North America held the largest share of the global market in 2025, which likely reflects earlier adoption and stronger healthcare capacity. - Asia-Pacific is expected to grow the fastest, signaling room for broader procedure adoption and infrastructure buildout.

What's next: - The report expects continued adoption of outpatient and ambulatory hysteroscopy as imaging and visualization improve. - Future growth will likely be tied to reimbursement support, healthcare expansion and more use of single-use devices. - The Business Research Company said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, market hotspot infographics and updated graphics and tables. - The company also listed contact details for expert follow-up and noted social media channels for more information.

The bottom line: - Hysteroscopy instruments are moving from a niche diagnostic toolset toward a broader, faster-growing market built on minimally invasive care and expanding women’s health demand.